Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Item
http://www.wikidata.org/entity/Q34031858
Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouseCritical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodiesDevelopment and Characterization of Monoclonal Antibodies Directed Against the Nucleoprotein of Heartland VirusCountermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSsThe nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responsesSerum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe diseaseThe dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.Interplay between the Virus and Host in Rift Valley Fever Pathogenesis.Innate Immune Basis for Rift Valley Fever Susceptibility in Mouse Models.Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome.Current Status of Rift Valley Fever Vaccine Development.Peripheral blood biomarkers of disease outcome in a monkey model of Rift Valley Fever encephalitis.Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection.
P2860

Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Item
http://www.wikidata.org/entity/Q34031858
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@ast
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@en
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@nl
type
label
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@ast
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@en
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@nl
prefLabel
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@ast
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@en
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Anti-nucleocapsid protein immu ...... fever virus infection in mice.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0025027
P407
P433
P478
P50
P577
P5875
P698
P921
P932